|
|
 |
| Firm name | AC-Sun ApS | | Address | Vitus Bering Innovation Park, Chr. M. Østergårdsvej 4, 8700 Horsens | | Contact person | Mads Salling-Mortensen | | Phone | +45 4017 9000 | | E-mail | msm@ac-sun.com | | Website | www.ac-sun.com | | Business area | Solar-powered air conditioning. | | Category | Cleantech | | Further information | AC-Sun ApS has invented a unique air conditioning system, which is primarily solar-powered and only uses a tenth of the power of traditional systems. | | Firm name | CarouCell | | Address | Aabogade 15, 8200 Aarhus N, Denmark | | Contact person | Lone Jager Lindquist | | Phone | +45-2087 9060 | | E-mail | lone@jagerlindquist.com | | Website | | | Business area | Dynamic bioreactor | | Category | Biotek/medico | | Further information | CarouCELL has developed a dynamic bioreactor. The product can develop 3D cells for the pharma industry. | | Firm name | Como Biotech ApS | | Address | Åbogade 15, DK-8200 Århus N | | Contact person | CEO Claus Oxvig | | Phone | +45-8620 5190 | | E-mail | | | Website | | | Business area | Como Biotech works with proteins for diagnostic/therapeutic purposes | | Category | Biotek/medico | | Further information | | | Firm name | ConTerra ApS | | Address | Agro Business Park, Niels Pedersens Allé 2, Postboks 10, DK-8830 Tjele, Denmark | | Contact person | CEO Holger Nehmdahl | | Phone | +45-8999 2540 | | E-mail | conterra@conterra | | Website | www.conterra.dk | | Business area | Development of IT tools that provide easy access to agricultural resource data.
| | Category | Cleantech | | Further information | ConTerra ApS is an advanced technology company with expertise in soil mapping, consequence analysis of cultivation practices and the development of GIS applications.
| | Firm name | Cytoguide ApS | | Address | Gustav Wieds Vej 10, DK-8000 Århus C | | Contact person | Jonas Heilskov Graversen | | Phone | +45 86205294 | | E-mail | info@cytoguide.dk | | Website | www.cytoguide.dk | | Business area | Targeted drug delivery. | | Category | Biotek/medico | | Further information | Cytoguide develops combinatory drugs (consisting of substances with documented effect bound to a protein partner) with specific delivery of active substances to macrophages. In this way, the side effects of known drugs can be prevented and the desired activity maintained, thus making the drugs more widely usable. |
|
